Clinical Implementation of Minimal Residual Disease Testing in Genitourinary Cancers: Bridging Promise and Practice.
作者信息
McKay Rana R, Lang Joshua, Beltran Himisha
机构信息
Department of Medicine and Urology, University of California San Diego, La Jolla, CA, USA.
Department of Medicine, University of Wisconsin, Madison, WI, USA.
出版信息
Eur Urol. 2025 Apr;87(4):424-426. doi: 10.1016/j.eururo.2024.11.023. Epub 2024 Dec 13.
Abstract
摘要
相似文献
1
Clinical Implementation of Minimal Residual Disease Testing in Genitourinary Cancers: Bridging Promise and Practice.泌尿生殖系统癌症微小残留病检测的临床应用：连接前景与实践
Eur Urol. 2025 Apr;87(4):424-426. doi: 10.1016/j.eururo.2024.11.023. Epub 2024 Dec 13.
2
Novel Methods to Assess Tumor Burden and Minimal Residual Disease in Genitourinary Cancers.评估泌尿生殖系统癌症肿瘤负荷和微小残留病的新方法。
Eur Urol. 2025 Apr;87(4):412-423. doi: 10.1016/j.eururo.2024.11.011. Epub 2024 Dec 5.
3
Circulating Tumor DNA in Genitourinary Cancers: Detection, Prognostics, and Therapeutic Implications.泌尿生殖系统癌症中的循环肿瘤DNA：检测、预后及治疗意义
Cancers (Basel). 2024 Jun 20;16(12):2280. doi: 10.3390/cancers16122280.
4
Myogenin and desmin immunohistochemistry in the assessment of post-chemotherapy genitourinary embryonal rhabdomyosarcoma: prognostic and management implications.肌生成素和结蛋白免疫组织化学在化疗后泌尿生殖系统胚胎性横纹肌肉瘤评估中的应用：对预后及治疗的意义
J Urol. 2006 Oct;176(4 Pt 2):1751-4. doi: 10.1016/j.juro.2006.03.117.
5
Hot topics in genitourinary cancers: A multidisciplinary discussion on state-of-the-art and latest developments among international experts and patient advocacy.泌尿生殖系统癌症热点问题：国际专家和患者权益倡导者对最新技术和最新进展的多学科讨论。
Tumori. 2024 Dec;110(6):410-415. doi: 10.1177/03008916241270093. Epub 2024 Oct 6.
6
Examining the trend of mortality of genitourinary system cancers in Babol, North Iran (2013-2021).探讨伊朗北部巴博勒地区泌尿系统癌症死亡率趋势（2013-2021 年）。
BMC Urol. 2024 Jul 30;24(1):161. doi: 10.1186/s12894-024-01523-7.
7
Integration of Patient Reported Outcomes in Drug Development in Genitourinary Cancers.将患者报告结局纳入泌尿生殖系统癌症药物研发中。
Curr Oncol Rep. 2020 Feb 8;22(3):21. doi: 10.1007/s11912-020-0890-3.
8
Identification of Patients With Stable Chest Pain Deriving Minimal Value From Noninvasive Testing: The PROMISE Minimal-Risk Tool, A Secondary Analysis of a Randomized Clinical Trial.从无创检查中获益极小的稳定型胸痛患者的识别：PROMISE 最小风险工具，一项随机临床试验的二次分析。
JAMA Cardiol. 2017 Apr 1;2(4):400-408. doi: 10.1001/jamacardio.2016.5501.
9
[Major neurological complications of genitourinary cancers].[泌尿生殖系统癌症的主要神经并发症]
Rev Neurol. 2018 Dec 1;67(11):441-452.
10
Oral microbiota in the oral-genitourinary axis: identifying periodontitis as a potential risk of genitourinary cancers.口腔-泌尿生殖道轴中的口腔微生物群：将牙周炎确定为泌尿生殖系统癌症的潜在风险。
Mil Med Res. 2021 Sep 29;8(1):54. doi: 10.1186/s40779-021-00344-1.
本文引用的文献
1
Novel Methods to Assess Tumor Burden and Minimal Residual Disease in Genitourinary Cancers.评估泌尿生殖系统癌症肿瘤负荷和微小残留病的新方法。
Eur Urol. 2025 Apr;87(4):412-423. doi: 10.1016/j.eururo.2024.11.011. Epub 2024 Dec 5.
2
Biological determinants of PSMA expression, regulation and heterogeneity in prostate cancer.前列腺癌中前列腺特异性膜抗原（PSMA）表达、调控及异质性的生物学决定因素
Nat Rev Urol. 2025 Jan;22(1):26-45. doi: 10.1038/s41585-024-00900-z. Epub 2024 Jul 8.
3
MicroRNA for Prediction of Teratoma and Viable Germ Cell Tumor after Chemotherapy.化疗后畸胎瘤和有活力生殖细胞瘤的预测的 microRNA。
Urol Clin North Am. 2024 Aug;51(3):387-394. doi: 10.1016/j.ucl.2024.03.007. Epub 2024 Apr 16.
4
MicroRNAs for detecting occult genitourinary cancer.检测隐匿性泌尿生殖系统癌症的 microRNAs。
Curr Opin Urol. 2024 Jan 1;34(1):20-26. doi: 10.1097/MOU.0000000000001137. Epub 2023 Nov 2.
5
Fragmentomic analysis of circulating tumor DNA-targeted cancer panels.循环肿瘤 DNA 靶向肿瘤面板的片段组学分析。
Ann Oncol. 2023 Sep;34(9):813-825. doi: 10.1016/j.annonc.2023.06.001. Epub 2023 Jun 16.
6
Landscape of prostate-specific membrane antigen heterogeneity and regulation in AR-positive and AR-negative metastatic prostate cancer.雄激素受体阳性和雄激素受体阴性转移性前列腺癌中前列腺特异性膜抗原异质性和调控的全景。
Nat Cancer. 2023 May;4(5):699-715. doi: 10.1038/s43018-023-00539-6. Epub 2023 Apr 10.
7
ctDNA guiding adjuvant immunotherapy in urothelial carcinoma.ctDNA 指导尿路上皮癌的辅助免疫治疗。
Nature. 2021 Jul;595(7867):432-437. doi: 10.1038/s41586-021-03642-9. Epub 2021 Jun 16.
8
Plasma cell-free DNA variant analysis compared with methylated DNA analysis in renal cell carcinoma.血浆无细胞游离 DNA 变异分析与肾细胞癌中甲基化 DNA 分析的比较。
Genet Med. 2020 Aug;22(8):1366-1373. doi: 10.1038/s41436-020-0801-x. Epub 2020 Apr 28.
Zotero 插件